Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Pseudo Biologist who wrote (4808)	11/20/1997 8:31:00 PM
From: aknahow	Respond to of 17367

Yes thats the report. Yes the wording does indicate Giroirs role but only with careful reading. E. Martin made this clear to me some time ago. The actual interviews were much longer and condensed for the report. I also believe the report provides a clear guide for the type and location of potential T.V. programs should events create real stories. While results will produce price moves by themselves utilization of appropriate T.V. stories should magnify the good news i and when it comes.

To: Pseudo Biologist who wrote (4808)	11/21/1997 1:17:00 PM
From: aknahow	Respond to of 17367

Pseudo, spoke to Ellen Martin, there is no double counting in the design of the Trauma trial. Just how many people got ill, regardless of having one or the other or both complications, and were the people who developed complications in the treated group or the placebo group. This should help reasure any analyst that had doubts or at least get them to seek confirmation and details from XOMA. I would hope that XOMA will provide this inormation on its web site so people wil not have to rely on a third parties post.